Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 280 shares of the company’s stock, valued at approximately $26,000.
A number of other large investors have also recently added to or reduced their stakes in GEHC. LGT Financial Advisors LLC lifted its position in GE HealthCare Technologies by 1,673.3% during the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares during the last quarter. Pathway Financial Advisers LLC acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at approximately $25,000. Fred Alger Management LLC acquired a new position in shares of GE HealthCare Technologies during the second quarter worth approximately $26,000. M&R Capital Management Inc. bought a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $33,000. Finally, Elkhorn Partners Limited Partnership acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $31,000. Institutional investors own 82.06% of the company’s stock.
Insider Activity at GE HealthCare Technologies
In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.27% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on GEHC
GE HealthCare Technologies Stock Performance
GE HealthCare Technologies stock opened at $85.39 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $66.39 and a 12-month high of $94.55. The stock has a 50-day simple moving average of $88.92 and a 200 day simple moving average of $83.48. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $39.01 billion, a price-to-earnings ratio of 23.46, a P/E/G ratio of 3.08 and a beta of 1.24.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the previous year, the company posted $0.99 earnings per share. The firm’s quarterly revenue was up .9% on a year-over-year basis. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is 3.30%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- 10 Best Airline Stocks to Buy
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- How to Invest in the Best Canadian Stocks
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- 3 Fintech Stocks With Good 2021 Prospects
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.